| ATKR | 8-K | bullish | 7/10 | Prysmian S.p.A. completed its acquisition of Atkore Inc. on October 19, 2026, for $95.00 per share in cash, totaling app | Oct 19, 2026 |
| EOSE | 8-K | mixed | 5/10 | Eos Energy Enterprises released preliminary Q3 2026 results showing revenue of $82M-$83M (169-172% YoY growth) and a GAA | Oct 19, 2026 |
| AASP | 8-K | neutral | 5/10 | Agassi Sports Entertainment Corp. raised $1.825M through a private placement and converted a $1M related-party note into | Oct 19, 2026 |
| FUL | 8-K | neutral | 5/10 | H.B. Fuller's Board unanimously rejected Ancora Holdings Group's second unsolicited, non-binding proposal to acquire the | Oct 19, 2026 |
| MKSI | 8-K | bullish | 6/10 | MKS Inc. announced it has entered into a definitive agreement to sell its Ophir Optics business to TTM Technologies, Inc | Oct 19, 2026 |
| TMS | 8-K | bullish | 6/10 | Teamshares Inc. entered into a $130 million senior secured term loan facility with Sound Point Capital affiliates, using | Oct 19, 2026 |
| TTMI | 8-K | bullish | 6/10 | TTM Technologies announced a definitive agreement to acquire the Ophir Optics business from MKS Inc. for approximately $ | Oct 19, 2026 |
| DFDV | 8-K | neutral | 3/10 | DeFi Development Corp. reported a modest weekly increase of 3,983 SOL and SOL equivalents, bringing total holdings to ap | Oct 19, 2026 |
| CJMB | 8-K | neutral | 4/10 | Callan JMB Inc. terminated its previously announced Asset Purchase and Sale Agreement to acquire a 50% interest in certa | Oct 19, 2026 |
| EXE | 8-K | neutral | 3/10 | Expand Energy appointed Daniel E. Brown as President and CEO, effective October 26, 2026, replacing interim CEO Michael | Oct 19, 2026 |
| AVBP | 8-K | bullish | 6/10 | ArriVent BioPharma announced the publication of Phase 1b (FURMO-002) results for firmonertinib in EGFR PACC-mutant NSCLC | Oct 19, 2026 |
| MAT | 8-K | neutral | 3/10 | Mattel announced the appointment of Peter Griffith as CFO and board director, effective October 20, 2026, succeeding Pau | Oct 19, 2026 |
| SLN | 8-K | bullish | 9/10 | Silence Therapeutics plc has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany in an | Oct 19, 2026 |
| CLNN | 8-K | bullish | 7/10 | Clene Inc. announced it has submitted a New Drug Application (NDA) to the FDA seeking accelerated approval of CNM-Au8 fo | Oct 19, 2026 |
| DX | 8-K | bearish | 6/10 | Dynex Capital reported Q3 2026 results showing a sharp decline in book value per common share to $10.91 from $12.90 in Q | Oct 19, 2026 |
| CRMD | 8-K | bullish | 7/10 | CorMedix announced that the FDA has accepted for filing and granted Priority Review to its supplemental New Drug Applica | Oct 19, 2026 |
| MSTR | 8-K | neutral | 4/10 | Strategy Inc disclosed weekly ATM activity, bitcoin purchases, and a board-approved increase in its digital credit secur | Oct 19, 2026 |
| SLE | 8-K | bullish | 7/10 | Stockholders approved all proposals related to Metaplanet's strategic investment, including the issuance of up to 435,85 | Oct 19, 2026 |
| ASST | 8-K | mixed | 5/10 | Strive, Inc. disclosed the purchase of 4,045 bitcoin for ~$335M at an average price of ~$82,803, funded by warrant exerc | Oct 19, 2026 |
| LEU | 8-K | bullish | 6/10 | Centrus Energy Corp. acquired 100% of Westerman Holdings, LLC, a key centrifuge component supplier and industrial fabric | Oct 19, 2026 |
| SLGN | 8-K | bullish | 7/10 | Silgan Holdings announced a transformative transaction to contribute its Metal Containers and Food & Beverage Flat Cap C | Oct 19, 2026 |
| NWSA | 8-K | neutral | 2/10 | News Corp filed an 8-K to disclose daily buy-back notifications provided to the ASX under its existing $1 billion repurc | Oct 19, 2026 |
| EQPT | 8-K | bullish | 6/10 | EquipmentShare raised its full-year 2026 guidance, increasing midpoint total revenue outlook to ~$5.927B from ~$5.468B ( | Oct 19, 2026 |
| MRKR | 8-K | bullish | 5/10 | Marker Therapeutics announced it was awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials Grants | Oct 19, 2026 |
| IRON | 8-K | bullish | 7/10 | Disc Medicine announced positive topline results from the pivotal Phase 3 APOLLO trial of bitopertin in erythropoietic p | Oct 19, 2026 |
| EYPT | 8-K | bearish | 7/10 | EyePoint announced that LUCIA, the second pivotal Phase 3 trial of DURAVYU in wet AMD, failed to meet its primary endpoi | Oct 19, 2026 |
| CBZ | 8-K | neutral | 4/10 | CBIZ reported Q3 2026 revenue of $702M (+1.2% YoY) and GAAP EPS of $0.79 (+64.6% YoY), with Adjusted EBITDA of $132M (+6 | Oct 19, 2026 |
| REKR | 8-K | bearish | 7/10 | Rekor Systems filed a verified complaint in Delaware Chancery Court against former director Viraj Mehta, alleging he bre | Oct 19, 2026 |
| CLF | 8-K | bullish | 7/10 | Cleveland-Cliffs reported Q3 2026 GAAP net income of $165M ($0.26 diluted) vs. a net loss of $134M in Q2 2026, with reve | Oct 19, 2026 |
| JEF | 8-K | neutral | 4/10 | Jefferies Financial Group held its 2026 Investor Meeting on October 19, 2026, posting a comprehensive investor presentat | Oct 19, 2026 |